This occurs secondarily to the LH3/PLOD3 p.(Asn223Ser), which introduces an additional glycosylation site within the enzyme’s GT domain, leading to osteogenesis imperfecta [18], and in the recently identified LH3/PLOD3 p.(Pro270Leu), which results in a Stickler-like syndrome with vascular complications and variable features typical of Ehlers–Danlos syndromes and Epidermolysis Bullosa [26]. Here, PLOD3 is linked to osteogenesis imperfecta.